Clinical Trial Update: The Value of 68Ga-FAPI PET/CT in the Efficacy Evaluation of Advanced Unresectable Hepatocellular Carcinoma Patients Undergoing Systemic Antitumor Therapy

View source ↗

Summary

A clinical trial evaluating the value of 68Ga-FAPI PET/CT imaging for assessing response to systemic therapy in patients with advanced unresectable hepatocellul…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Snippet

Sponsor: Ruijin Hospital | Conditions: Hepatocellular Carcinoma (HCC) | Status: RECRUITING